Speaker Biography
Randolph L. Winter
DVM, PhD, DACVIM (Cardiology)
Associate Professor, Cardiology, Auburn University College of Veterinary Medicine
Dr. Randolph Winter received his DVM degree from Texas A&M University College of Veterinary Medicine and Biomedical Sciences in 2010. He then completed a rotating internship in Small Animal Medicine and Surgery at Colorado State University. Afterwards he returned to Texas A&M to complete his Cardiology Residency, and he became a Diplomat of the American College of Veterinary Internal Medicine, subspecialty Cardiology, in 2014.
Dr. Winter then became a faculty member in Cardiology at Auburn University College of Veterinary Medicine from 2014 – 2018, during which time he completed a PhD degree in Biomedical Science. From 2019-2021, Dr. Winter was a faculty member at Ohio State University College of Veterinary Medicine.
Lectures
-
Friday, October 30, 2026 9:45 - 10:35 a.m. Auditorium
Mitral Valve Degeneration: What is Known and What is New Small Animal I
In this presentation, participants will learn about how the pathophysiology of myxomatous mitral valve degeneration (MMVD) leads to clinically relevant consequences, as well as what diagnostic and therapeutic options that exist for this disease.
Learning objectives:
- Participants will review the pathophysiology of myxomatous mitral valve disease (MMVD)
- Participants will understand how clinical sequelae of MMVD occur
- Participants will learn about new options to address this disease
-
Friday, October 30, 2026 10:45 - 11:35 a.m. Auditorium
Treating Non-Cardiac Diseases in the Cath Lab: Case Discussions Small Animal I
In this presentation, systemic diseases that have hemodynamic consequences will be reviewed with a variety of imaging modalities with the goal of understanding how interventional procedures can aid in the clinical management of a variety of diseases.
Learning objectives:
- Participants will understand how systemic diseases can have hemodynamic consequences
- Participants will learn about what interventional options exist for systemic diseases